Advancing our understanding of Breast Cancer
Find out how the UKCRC Tissue Directory helped a researcher access the samples he needed for his research.
Cancer
Collaborators needed for new Keratinocyte Cancer Collaborative
Collaborators needed for new Keratinocyte Cancer Collaborative Thanks to the registration of skin cancer pathology reports, the biggest database on skin cancer in the world now exists through Public Health England (PHE) with input from the devolved nations. In order to build on this resource a new UK Keratinocyte Cancer Collaborative (UKKCC) is being established with support from the British Association of Dermatologists. We find out more from Dr Paul… Read More »Collaborators needed for new Keratinocyte Cancer Collaborative
NC3Rs Workshop: Human tissue models for cancer research
NC3Rs Workshop: Human tissue models for cancer research On 1st and 2nd of March , the UKCRC TDCC attended the NC3Rs workshop: Human tissue models for cancer research. Here, we outline the day’s events and what we learned. The first day was opened by Prof Gareth Thomas who gave a pathologists perspective, highlighting the importance of the tumour microenvironment which means research should focus on more than studying single cells.… Read More »NC3Rs Workshop: Human tissue models for cancer research
Working together: Collaboration in the cancer biobanking landscape
Working together: Collaboration in the cancer biobanking landscape On 17th October, the UKCRC TDCC attended the Confederation of Cancer Biobanks (CCB) and CM-Path’s joint meeting ‘Working together: Collaboration in the cancer biobanking landscape’. The day was a great opportunity to bring together colleagues from throughout the UK to discuss the challenges and opportunities currently developing in the Cancer landscape. Dr Phil Quinlan presenting UKCRC TDCC The Confederation of Cancer Biobanks… Read More »Working together: Collaboration in the cancer biobanking landscape
Spotlight on: Ana Rio-Machin
Spotlight on: Ana Rio-Machin Job title: Postdoctoral Researcher at Barts Cancer Institute (BCI), Queen Mary University of London Research Project: Ana researches the genetic alterations (mutations) that are inherited in families who have leukaemia without a known cause, within a Bloodwise funded programme; ‘Acute Myeloid Leukaemia (AML) familial cases, where two or more affected individuals are found in the same family, are rare but represent a high-risk group of patients… Read More »Spotlight on: Ana Rio-Machin